Table 2. Characteristics of patients... | American Society of Hematology

Table 2.

Characteristics of patients with biopsy-proven CTCL SS

Patient ID	Diagnosis	Stage at diagnosis	Age at diagnosis, y	Sex	Race	Clonality on initial flow cytometric analysis
69	CTCL, SS	IVA1	51	M	White	84% CD3⁺/CD26^– T-cells; 82% CD4⁺/CD26^–; 75% CD7⁺/CD26^–
76	CTCL, SS	III	82	F	White	22% CD3⁺/CD4⁺/CD7^– T-cells
86	CTCL, SS	IVA1	77	F	White	92% CD3⁺/CD4⁺/CD26^–; 22% CD3⁺/CD4⁺/CD7^–
96	CTCL, SS	IVA1	67	M	White	82% CD3⁺/CD26^–/CD2^–
135	CTCL, SS	IVA1	59	F	White	92% CD3⁺/CD26^–
164	CTCL, SS	IVA1	60	F	White	63% CD3⁺/CD4⁺/CD7⁺/CD26^–; 34% CD3⁺/CD4^–/CD8^–/CD7^–/CD26^–
187	CTCL, SS	IVA1	64	M	African American	60% CD3⁺/CD26^–; 50% CD3 biphasic/CD7^–
224	CTCL, SS	IVA1	82	M	White	98% CD2⁺/CD4⁺/CD5⁺/CD3^–/CD7^–/CD8^–/CD26^–
227	CTCL, SS	IVA1	56	M	White	93% CD4⁺/CD26^–

Patient ID	Diagnosis	Stage at diagnosis	Age at diagnosis, y	Sex	Race	Clonality on initial flow cytometric analysis
69	CTCL, SS	IVA1	51	M	White	84% CD3⁺/CD26^– T-cells; 82% CD4⁺/CD26^–; 75% CD7⁺/CD26^–
76	CTCL, SS	III	82	F	White	22% CD3⁺/CD4⁺/CD7^– T-cells
86	CTCL, SS	IVA1	77	F	White	92% CD3⁺/CD4⁺/CD26^–; 22% CD3⁺/CD4⁺/CD7^–
96	CTCL, SS	IVA1	67	M	White	82% CD3⁺/CD26^–/CD2^–
135	CTCL, SS	IVA1	59	F	White	92% CD3⁺/CD26^–
164	CTCL, SS	IVA1	60	F	White	63% CD3⁺/CD4⁺/CD7⁺/CD26^–; 34% CD3⁺/CD4^–/CD8^–/CD7^–/CD26^–
187	CTCL, SS	IVA1	64	M	African American	60% CD3⁺/CD26^–; 50% CD3 biphasic/CD7^–
224	CTCL, SS	IVA1	82	M	White	98% CD2⁺/CD4⁺/CD5⁺/CD3^–/CD7^–/CD8^–/CD26^–
227	CTCL, SS	IVA1	56	M	White	93% CD4⁺/CD26^–